Janice L Pasieka Selected Research

Janice L Pasieka Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 03/2002
7	Thyroid Neoplasms (Thyroid Cancer) 10/2016 - 01/2002
6	Primary Hyperparathyroidism 08/2015 - 08/2002
6	Carcinoid Tumor (Carcinoid) 01/2015 - 03/2002
5	Hyperaldosteronism (Conn Syndrome) 01/2021 - 01/2008
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015 - 03/2002
4	Pheochromocytoma 03/2022 - 03/2006
3	Paraganglioma (Paragangliomas) 03/2022 - 03/2006
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 05/2007 - 08/2004
2	Papillary Thyroid Cancer 01/2020 - 10/2016
2	Neoplasm Metastasis (Metastasis) 10/2016 - 11/2010
2	Hyperparathyroidism 12/2009 - 12/2002
2	Lymphoma (Lymphomas) 05/2007 - 08/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2007 - 12/2006
2	Anaplastic Thyroid Carcinoma 04/2004 - 01/2003
1	Cushing Syndrome 03/2022
1	Atrophy 03/2022
1	Pituitary Neoplasms (Pituitary Adenoma) 03/2022
1	COVID-19 01/2022
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 10/2016
1	Vitamin D Deficiency 10/2016
1	Thyroid Diseases (Thyroid Disease) 10/2016
1	Nausea 01/2015
1	Hyperglycemia 01/2015
1	Fatigue 01/2015
1	Hypokalemia 07/2014
1	Adenoma (Adenomas) 04/2014
1	Cognitive Dysfunction 02/2014
1	Meckel Diverticulum 01/2011
1	Abdominal Pain (Pain, Abdominal) 10/2009
1	Carcinoma (Carcinomatosis) 10/2009
1	Autoimmune Diseases (Autoimmune Disease) 09/2009
1	Hematologic Diseases (Blood Diseases) 09/2009
1	Adenocarcinoma 01/2007
1	Pellagra 10/2005
1	Wounds and Injuries (Trauma) 01/2002
1	Hyperthyroidism 01/2002
1	Hemorrhage 01/2002

Drug/Important Bio-Agent (IBA)

4	Octreotide (Sandostatin)FDA LinkGeneric 01/2015 - 03/2002
4	AldosteroneIBA 12/2014 - 01/2008
4	Biological ProductsIBA 10/2009 - 04/2004
3	CalciumIBA 10/2016 - 06/2004
3	Serotonin (5 Hydroxytryptamine)IBA 02/2014 - 10/2005
2	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2022 - 07/2013
2	NormetanephrineIBA 01/2022 - 01/2021
2	Cosyntropin (Cortrosyn)FDA LinkGeneric 01/2018 - 12/2014
2	IodineIBA 10/2016 - 12/2015
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2015 - 03/2002
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2014 - 07/2013
2	Parathyroid Hormone (Parathormone)IBA 05/2014 - 04/2014
2	indium-111-octreotideIBA 11/2010 - 12/2004
2	3-Iodobenzylguanidine (Iobenguane)IBA 12/2004 - 11/2004
1	SuspensionsIBA 01/2022
1	MetanephrineIBA 01/2021
1	25-hydroxyvitamin DIBA 10/2016
1	Thyroid HormonesIBA 12/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	pasireotideIBA 01/2015
1	ReninIBA 07/2014
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Hormones (Hormone)IBA 09/2009
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 03/2006
1	Peptides (Polypeptides)IBA 03/2006
1	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 10/2005
1	NAD (NADH)IBA 10/2005
1	NADP (NADPH)IBA 10/2005
1	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2005
1	Tryptophan (L-Tryptophan)FDA Link 10/2005
1	Indicators and Reagents (Reagents)IBA 10/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2004
1	Prednisone (Sone)FDA LinkGeneric 08/2004
1	Vincristine (Oncovin)FDA LinkGeneric 08/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2004
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2002
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2002

Therapy/Procedure

8	Therapeutics 05/2007 - 01/2002
5	Parathyroidectomy 10/2016 - 08/2002
4	Thyroidectomy 01/2020 - 08/2004
4	Laparotomy 01/2011 - 01/2002
3	Drug Therapy (Chemotherapy) 09/2009 - 08/2004
2	Adrenalectomy 01/2021 - 01/2008
2	Neck Dissection (Radical Neck Dissection) 10/2016 - 01/2016
2	Palliative Care (Palliative Therapy) 05/2007 - 03/2002
2	Biological Therapy 01/2007 - 11/2004
1	Operative Time 01/2022
1	Length of Stay 01/2022
1	Precision Medicine 12/2015
1	Catheters 07/2013
1	Radiofrequency Ablation 01/2007
1	Nutritional Support (Artificial Feeding) 10/2005
1	Ligation 01/2002
1	Punctures 01/2002